Last updated: December 15, 2024
Sponsor: Ningbo No. 1 Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
Hemorrhage
Polyps
Treatment
hot snare polypectomy
cold snare polypectomy
Clinical Study ID
NCT06097650
2023-140A-YJ01
Ages 18-75 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients undergoing endoscopic resection of small and medium pedicled polyps inthe First Affiliated Hospital of Ningbo University from October 2023 to August 2026; 2. Age 18-75 years old; 3. Patients who voluntarily agreed to participatein this study and signed informed consent.
Exclusion
Exclusion Criteria:
- Persons under 18 years of age 2. Persons unwilling or unable to provideinformed consent 3. Treatment or radiotherapy for malignant diseases, severechronic heart or lung diseases, coronary or cerebrovascular events requiringhospitalization within the last 3 months 4.Malignant polyps have infiltratedthe pedicle 5. Abdominal symptoms such as severe abdominal pain, abdominaldistension, and nausea 6.Patients with inadequate intestinal preparation 7.Patients with lifelong anticoagulant therapy or severe bleeding diseases,patients who have recently taken anticoagulant drugs or antiplatelet drugs (within 1 week) 8.Pregnant or lactating
Study Design
Total Participants: 196
Treatment Group(s): 2
Primary Treatment: hot snare polypectomy
Phase:
Study Start date:
October 18, 2023
Estimated Completion Date:
August 31, 2026
Connect with a study center
Ningbo first hospital
Ningbo, Zhejiang 315000
ChinaActive - Recruiting
the First Affiliated Hospital of Ningbo University
Ningbo, Zhejiang 315000
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.